Skip to main content
Erschienen in: Neurocritical Care 3/2016

04.09.2015 | Original Article

TURN Score Predicts 24-Hour Cerebral Edema After IV Thrombolysis

verfasst von: David Asuzu, Karin Nyström, Anirudh Sreekrishnan, Joseph Schindler, Charles Wira, David Greer, Janet Halliday, W. Taylor Kimberly, Kevin N. Sheth

Erschienen in: Neurocritical Care | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Background and Purpose

Cerebral edema is associated with poor outcome after IV thrombolysis. We recently described the TURN score (Thrombolysis risk Using mRS and NIHSS), a predictor of severe outcome after IV thrombolysis. Our purpose was to evaluate its ability to predict 24-h cerebral edema.

Methods

We retrospectively analyzed data from 303 patients who received IV rt-PA during the NINDS rt-PA trial. Measures of brain swelling included edema, mass effect and midline shift assessed at baseline, at 24 h and new onset at 24 h. Outcome was assessed using intracerebral hemorrhage (ICH), symptomatic intracerebral hemorrhage (sICH), 90-day severe outcome, and 90-day mortality. Statistical associations were assessed by logistic regression reporting odds ratios (OR) and by areas under the receiver operating characteristic curves (AUROC).

Results

Baseline brain swelling did not predict poor outcome; however, 24-h brain swelling predicted ICH (OR 5.69, P < 0.001), sICH (OR 9.50, P = 0.01), 90-day severe outcome (OR 7.10, P < 0.001), and 90-day mortality (OR 5.65, P = 0.01). Similar results were seen for new brain swelling at 24 h. TURN predicted 24-hour brain swelling (OR 2.5, P < 0.001; AUROC 0.69, 95 % CI 0.63–0.75) and new brain swelling at 24 h (OR 2.1, P < 0.001; AUROC 0.67, 95 % CI 0.61–0.73).

Conclusions

Cerebral edema at 24 h is associated with poor outcome and 90-day mortality. TURN predicts ischemic stroke patients who will develop 24-h cerebral edema after IV thrombolysis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–245.CrossRefPubMed Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–245.CrossRefPubMed
2.
Zurück zum Zitat TNIoNDa S. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581–7.CrossRef TNIoNDa S. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581–7.CrossRef
3.
Zurück zum Zitat Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). J Am Med Assoc. 1995;274:1017–25.CrossRef Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). J Am Med Assoc. 1995;274:1017–25.CrossRef
4.
Zurück zum Zitat Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352:1245–51.CrossRefPubMed Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352:1245–51.CrossRefPubMed
5.
Zurück zum Zitat Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J med. 2008;359:1317–29.CrossRefPubMed Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J med. 2008;359:1317–29.CrossRefPubMed
6.
Zurück zum Zitat Weiser RE, Sheth KN. Clinical predictors and management of hemorrhagic transformation. Curr Treat Options Neurol. 2013;15:125–49.CrossRefPubMed Weiser RE, Sheth KN. Clinical predictors and management of hemorrhagic transformation. Curr Treat Options Neurol. 2013;15:125–49.CrossRefPubMed
7.
Zurück zum Zitat Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 2007;6:258–68.CrossRefPubMedPubMedCentral Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 2007;6:258–68.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Urday S, Kimberly WT, Beslow LA, et al. Targeting secondary injury in intracerebral haemorrhage—perihaematomal oedema. Nat Rev Neurol. 2015;11:111–22.CrossRefPubMed Urday S, Kimberly WT, Beslow LA, et al. Targeting secondary injury in intracerebral haemorrhage—perihaematomal oedema. Nat Rev Neurol. 2015;11:111–22.CrossRefPubMed
9.
Zurück zum Zitat Wijdicks EF, Sheth KN, Carter BS, et al. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:1222–38.CrossRefPubMed Wijdicks EF, Sheth KN, Carter BS, et al. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45:1222–38.CrossRefPubMed
10.
Zurück zum Zitat Hom J, Dankbaar JW, Soares BP, et al. Blood-brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant edema in acute ischemic stroke. Am J Neuroradiol. 2011;32:41–8.CrossRefPubMed Hom J, Dankbaar JW, Soares BP, et al. Blood-brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant edema in acute ischemic stroke. Am J Neuroradiol. 2011;32:41–8.CrossRefPubMed
11.
Zurück zum Zitat Urday S, Beslow LA, Goldstein DW, et al. Measurement of perihematomal edema in intracerebral hemorrhage. Stroke. 2015;46:1116–9.CrossRefPubMed Urday S, Beslow LA, Goldstein DW, et al. Measurement of perihematomal edema in intracerebral hemorrhage. Stroke. 2015;46:1116–9.CrossRefPubMed
13.
Zurück zum Zitat Asuzu D, Nystrom K, Amin H, et al. TURN: a simple predictor of symptomatic intracerebral hemorrhage after IV thrombolysis. Neurocrit care. 2015;. doi:10.1007/s12028-015-0131-z. Asuzu D, Nystrom K, Amin H, et al. TURN: a simple predictor of symptomatic intracerebral hemorrhage after IV thrombolysis. Neurocrit care. 2015;. doi:10.​1007/​s12028-015-0131-z.
14.
Zurück zum Zitat Asuzu D, Nystrom K, Schindler J, et al. TURN score predicts 90-day outcome in acute ischemic stroke patients after IV thrombolysis. Neurocrit care. 2015;. doi:10.1007/s12028-015-0154-5. Asuzu D, Nystrom K, Schindler J, et al. TURN score predicts 90-day outcome in acute ischemic stroke patients after IV thrombolysis. Neurocrit care. 2015;. doi:10.​1007/​s12028-015-0154-5.
16.
Zurück zum Zitat Patel SC, Levine SR, Tilley BC, et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. J Am Med Assoc. 2001;286:2830–8.CrossRef Patel SC, Levine SR, Tilley BC, et al. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. J Am Med Assoc. 2001;286:2830–8.CrossRef
17.
Zurück zum Zitat Uk-Tia Study Group. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results UK-TIA Study Group. Br Med J. 1988;296:316–20.CrossRef Uk-Tia Study Group. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results UK-TIA Study Group. Br Med J. 1988;296:316–20.CrossRef
18.
Zurück zum Zitat van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–7.CrossRefPubMed van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–7.CrossRefPubMed
19.
Zurück zum Zitat Asuzu D, Nystrom K, Amin H, et al. Comparison of 8 Scores for predicting Symptomatic Intracerebral Hemorrhage after IV Thrombolysis. Neurocrit care. 2014;22(2):229–33.CrossRef Asuzu D, Nystrom K, Amin H, et al. Comparison of 8 Scores for predicting Symptomatic Intracerebral Hemorrhage after IV Thrombolysis. Neurocrit care. 2014;22(2):229–33.CrossRef
20.
Zurück zum Zitat Kent DM, Selker HP, Ruthazer R, Bluhmki E, Hacke W. The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke. 2006;37:2957–62.CrossRefPubMed Kent DM, Selker HP, Ruthazer R, Bluhmki E, Hacke W. The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke. 2006;37:2957–62.CrossRefPubMed
21.
Zurück zum Zitat Strbian D, Engelter S, Michel P, et al. Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Ann neurol. 2012;71:634–41.CrossRefPubMed Strbian D, Engelter S, Michel P, et al. Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score. Ann neurol. 2012;71:634–41.CrossRefPubMed
22.
Zurück zum Zitat Saposnik G, Guzik AK, Reeves M, Ovbiagele B, Johnston SC. Stroke prognostication using Age and NIH Stroke Scale: SPAN-100. Neurology. 2013;80:21–8.CrossRefPubMedPubMedCentral Saposnik G, Guzik AK, Reeves M, Ovbiagele B, Johnston SC. Stroke prognostication using Age and NIH Stroke Scale: SPAN-100. Neurology. 2013;80:21–8.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Ntaios G, Faouzi M, Ferrari J, Lang W, Vemmos K, Michel P. An integer-based score to predict functional outcome in acute ischemic stroke: the ASTRAL score. Neurology. 2012;78:1916–22.CrossRefPubMed Ntaios G, Faouzi M, Ferrari J, Lang W, Vemmos K, Michel P. An integer-based score to predict functional outcome in acute ischemic stroke: the ASTRAL score. Neurology. 2012;78:1916–22.CrossRefPubMed
24.
Zurück zum Zitat Lou M, Safdar A, Mehdiratta M, et al. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology. 2008;71:1417–23.CrossRefPubMedPubMedCentral Lou M, Safdar A, Mehdiratta M, et al. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology. 2008;71:1417–23.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982;115:92–106.PubMed Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982;115:92–106.PubMed
26.
Zurück zum Zitat DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.CrossRefPubMed
27.
Zurück zum Zitat Welch BL. The generalisation of student’s problems when several different population variances are involved. Biometrika. 1947;34:28–35.PubMed Welch BL. The generalisation of student’s problems when several different population variances are involved. Biometrika. 1947;34:28–35.PubMed
28.
Zurück zum Zitat Serena J, Blanco M, Castellanos M, et al. The prediction of malignant cerebral infarction by molecular brain barrier disruption markers. Stroke. 2005;36:1921–6.CrossRefPubMed Serena J, Blanco M, Castellanos M, et al. The prediction of malignant cerebral infarction by molecular brain barrier disruption markers. Stroke. 2005;36:1921–6.CrossRefPubMed
29.
Zurück zum Zitat Bisdas S, Hartel M, Cheong LH, Koh TS. Detection of early vessel leakiness in acute ischemic stroke using computed tomography perfusion may indicate hemorrhagic transformation. Acta Radiol. 2007;48:341–4.CrossRefPubMed Bisdas S, Hartel M, Cheong LH, Koh TS. Detection of early vessel leakiness in acute ischemic stroke using computed tomography perfusion may indicate hemorrhagic transformation. Acta Radiol. 2007;48:341–4.CrossRefPubMed
30.
Zurück zum Zitat Bisdas S, Hartel M, Cheong LH, Koh TS, Vogl TJ. Prediction of subsequent hemorrhage in acute ischemic stroke using permeability CT imaging and a distributed parameter tracer kinetic model. J Neuroradiol. 2007;34:101–8.CrossRefPubMed Bisdas S, Hartel M, Cheong LH, Koh TS, Vogl TJ. Prediction of subsequent hemorrhage in acute ischemic stroke using permeability CT imaging and a distributed parameter tracer kinetic model. J Neuroradiol. 2007;34:101–8.CrossRefPubMed
31.
Zurück zum Zitat Lin K, Kazmi KS, Law M, Babb J, Peccerelli N, Pramanik BK. Measuring elevated microvascular permeability and predicting hemorrhagic transformation in acute ischemic stroke using first-pass dynamic perfusion CT imaging. Am J Neuroradiol. 2007;28:1292–8.CrossRefPubMed Lin K, Kazmi KS, Law M, Babb J, Peccerelli N, Pramanik BK. Measuring elevated microvascular permeability and predicting hemorrhagic transformation in acute ischemic stroke using first-pass dynamic perfusion CT imaging. Am J Neuroradiol. 2007;28:1292–8.CrossRefPubMed
32.
Zurück zum Zitat Kassner A, Roberts T, Taylor K, Silver F, Mikulis D. Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging. Am J Neuroradiol. 2005;26:2213–7.PubMed Kassner A, Roberts T, Taylor K, Silver F, Mikulis D. Prediction of hemorrhage in acute ischemic stroke using permeability MR imaging. Am J Neuroradiol. 2005;26:2213–7.PubMed
33.
Zurück zum Zitat Tsuji K, Aoki T, Tejima E, et al. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke. 2005;36:1954–9.CrossRefPubMed Tsuji K, Aoki T, Tejima E, et al. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke. 2005;36:1954–9.CrossRefPubMed
34.
Zurück zum Zitat Wang X, Lee SR, Arai K, et al. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med. 2003;9:1313–7.CrossRefPubMed Wang X, Lee SR, Arai K, et al. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med. 2003;9:1313–7.CrossRefPubMed
35.
Zurück zum Zitat Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Investig. 2003;112:1533–40.CrossRefPubMedPubMedCentral Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Investig. 2003;112:1533–40.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Wijdicks EF, Diringer MN. Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome. Mayo Clin Proc. 1998;73:829–36.CrossRefPubMed Wijdicks EF, Diringer MN. Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome. Mayo Clin Proc. 1998;73:829–36.CrossRefPubMed
37.
Zurück zum Zitat Kimberly WT, Battey TW, Pham L, et al. Glyburide is associated with attenuated vasogenic edema in stroke patients. Neurocrit Care. 2014;20:193–201.CrossRefPubMed Kimberly WT, Battey TW, Pham L, et al. Glyburide is associated with attenuated vasogenic edema in stroke patients. Neurocrit Care. 2014;20:193–201.CrossRefPubMed
38.
Zurück zum Zitat Asuzu D, Nystrom K, Amin H, et al. Cohort-Based Identification of Predictors of Symptomatic Intracerebral Hemorrhage After IV thrombolysis. Neurocrit care. 2015;. doi:10.1007/s12028-015-0121-1. Asuzu D, Nystrom K, Amin H, et al. Cohort-Based Identification of Predictors of Symptomatic Intracerebral Hemorrhage After IV thrombolysis. Neurocrit care. 2015;. doi:10.​1007/​s12028-015-0121-1.
39.
Zurück zum Zitat Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864–70.CrossRefPubMed Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864–70.CrossRefPubMed
40.
Zurück zum Zitat Dewey HM, Donnan GA, Freeman EJ, et al. Interrater reliability of the National Institutes of Health Stroke Scale: rating by neurologists and nurses in a community-based stroke incidence study. Cerebrovasc dis. 1999;9:323–7.CrossRefPubMed Dewey HM, Donnan GA, Freeman EJ, et al. Interrater reliability of the National Institutes of Health Stroke Scale: rating by neurologists and nurses in a community-based stroke incidence study. Cerebrovasc dis. 1999;9:323–7.CrossRefPubMed
41.
Zurück zum Zitat Garvin P, Nilsson L, Carstensen J, Jonasson L, Kristenson M. Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population. PLoS One. 2008;3:e1774.CrossRefPubMedPubMedCentral Garvin P, Nilsson L, Carstensen J, Jonasson L, Kristenson M. Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population. PLoS One. 2008;3:e1774.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Montaner J, Alvarez-Sabin J, Molina C, et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke. 2001;32:1759–66.CrossRefPubMed Montaner J, Alvarez-Sabin J, Molina C, et al. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke. 2001;32:1759–66.CrossRefPubMed
Metadaten
Titel
TURN Score Predicts 24-Hour Cerebral Edema After IV Thrombolysis
verfasst von
David Asuzu
Karin Nyström
Anirudh Sreekrishnan
Joseph Schindler
Charles Wira
David Greer
Janet Halliday
W. Taylor Kimberly
Kevin N. Sheth
Publikationsdatum
04.09.2015
Verlag
Springer US
Erschienen in
Neurocritical Care / Ausgabe 3/2016
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-015-0198-6

Weitere Artikel der Ausgabe 3/2016

Neurocritical Care 3/2016 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.